nodes	percent_of_prediction	percent_of_DWPC	metapath
Nilutamide—AR—hematologic cancer	0.307	1	CbGaD
Nilutamide—POR—Daunorubicin—hematologic cancer	0.177	0.385	CbGbCtD
Nilutamide—POR—Doxorubicin—hematologic cancer	0.0462	0.101	CbGbCtD
Nilutamide—CYP2C9—Bexarotene—hematologic cancer	0.0203	0.0442	CbGbCtD
Nilutamide—CYP2C8—Bortezomib—hematologic cancer	0.0179	0.0389	CbGbCtD
Nilutamide—CYP2C9—Idarubicin—hematologic cancer	0.0168	0.0367	CbGbCtD
Nilutamide—CYP2C19—Bortezomib—hematologic cancer	0.015	0.0326	CbGbCtD
Nilutamide—CYP2C8—Ifosfamide—hematologic cancer	0.0137	0.0298	CbGbCtD
Nilutamide—CYP2C19—Thalidomide—hematologic cancer	0.013	0.0284	CbGbCtD
Nilutamide—CYP2C9—Bortezomib—hematologic cancer	0.0125	0.0271	CbGbCtD
Nilutamide—CYP2C19—Teniposide—hematologic cancer	0.0124	0.0271	CbGbCtD
Nilutamide—CYP2C8—Nilotinib—hematologic cancer	0.0119	0.0259	CbGbCtD
Nilutamide—CYP2C19—Ifosfamide—hematologic cancer	0.0115	0.025	CbGbCtD
Nilutamide—CYP2C19—Imatinib—hematologic cancer	0.011	0.0239	CbGbCtD
Nilutamide—CYP2C9—Thalidomide—hematologic cancer	0.0108	0.0236	CbGbCtD
Nilutamide—CYP2C9—Teniposide—hematologic cancer	0.0103	0.0225	CbGbCtD
Nilutamide—CYP2C9—Ifosfamide—hematologic cancer	0.00955	0.0208	CbGbCtD
Nilutamide—CYP2C9—Imatinib—hematologic cancer	0.00912	0.0199	CbGbCtD
Nilutamide—CYP2C9—Nilotinib—hematologic cancer	0.00829	0.0181	CbGbCtD
Nilutamide—CYP2C19—Prednisone—hematologic cancer	0.00723	0.0157	CbGbCtD
Nilutamide—CYP2C8—Etoposide—hematologic cancer	0.00654	0.0143	CbGbCtD
Nilutamide—CYP2C8—Dexamethasone—hematologic cancer	0.00538	0.0117	CbGbCtD
Nilutamide—CYP2C9—Cisplatin—hematologic cancer	0.00465	0.0101	CbGbCtD
Nilutamide—CYP2C19—Dexamethasone—hematologic cancer	0.00451	0.00983	CbGbCtD
Nilutamide—CYP2C9—Dexamethasone—hematologic cancer	0.00375	0.00817	CbGbCtD
Nilutamide—Flutamide—AR—hematologic cancer	0.00103	0.396	CrCbGaD
Nilutamide—Enzalutamide—AR—hematologic cancer	0.000944	0.362	CrCbGaD
Nilutamide—POR—blood—hematologic cancer	0.000686	0.0845	CbGeAlD
Nilutamide—POR—bone marrow—hematologic cancer	0.000664	0.0818	CbGeAlD
Nilutamide—AR—hematopoietic system—hematologic cancer	0.000612	0.0754	CbGeAlD
Nilutamide—POR—lung—hematologic cancer	0.000602	0.0741	CbGeAlD
Nilutamide—POR—testis—hematologic cancer	0.000568	0.0699	CbGeAlD
Nilutamide—CYP2C19—hematopoietic system—hematologic cancer	0.000567	0.0699	CbGeAlD
Nilutamide—CYP2C8—hematopoietic system—hematologic cancer	0.000495	0.061	CbGeAlD
Nilutamide—AR—gonad—hematologic cancer	0.000465	0.0573	CbGeAlD
Nilutamide—CYP2C9—hematopoietic system—hematologic cancer	0.00044	0.0542	CbGeAlD
Nilutamide—POR—lymph node—hematologic cancer	0.000411	0.0507	CbGeAlD
Nilutamide—AR—blood—hematologic cancer	0.000405	0.05	CbGeAlD
Nilutamide—CYP2C19—blood—hematologic cancer	0.000376	0.0463	CbGeAlD
Nilutamide—AR—lung—hematologic cancer	0.000355	0.0438	CbGeAlD
Nilutamide—AR—testis—hematologic cancer	0.000335	0.0413	CbGeAlD
Nilutamide—CYP2C8—blood—hematologic cancer	0.000328	0.0404	CbGeAlD
Nilutamide—Enzalutamide—ALB—hematologic cancer	0.000324	0.124	CrCbGaD
Nilutamide—Enzalutamide—ABCB1—hematologic cancer	0.000309	0.118	CrCbGaD
Nilutamide—CYP2C9—blood—hematologic cancer	0.000291	0.0359	CbGeAlD
Nilutamide—CYP2C8—testis—hematologic cancer	0.000271	0.0334	CbGeAlD
Nilutamide—AR—lymph node—hematologic cancer	0.000243	0.03	CbGeAlD
Nilutamide—Dizziness—Irinotecan—hematologic cancer	3.69e-05	0.000195	CcSEcCtD
Nilutamide—Malaise—Prednisone—hematologic cancer	3.67e-05	0.000194	CcSEcCtD
Nilutamide—Rhinitis—Epirubicin—hematologic cancer	3.67e-05	0.000194	CcSEcCtD
Nilutamide—Abdominal pain—Etoposide—hematologic cancer	3.66e-05	0.000194	CcSEcCtD
Nilutamide—Body temperature increased—Etoposide—hematologic cancer	3.66e-05	0.000194	CcSEcCtD
Nilutamide—Urinary tract infection—Doxorubicin—hematologic cancer	3.66e-05	0.000194	CcSEcCtD
Nilutamide—Syncope—Prednisone—hematologic cancer	3.65e-05	0.000193	CcSEcCtD
Nilutamide—Hypoaesthesia—Epirubicin—hematologic cancer	3.64e-05	0.000192	CcSEcCtD
Nilutamide—Vomiting—Vincristine—hematologic cancer	3.64e-05	0.000192	CcSEcCtD
Nilutamide—Anorexia—Dexamethasone—hematologic cancer	3.64e-05	0.000192	CcSEcCtD
Nilutamide—Anorexia—Betamethasone—hematologic cancer	3.64e-05	0.000192	CcSEcCtD
Nilutamide—Asthenia—Cisplatin—hematologic cancer	3.63e-05	0.000192	CcSEcCtD
Nilutamide—Sweating—Doxorubicin—hematologic cancer	3.61e-05	0.000191	CcSEcCtD
Nilutamide—Urinary tract disorder—Epirubicin—hematologic cancer	3.61e-05	0.000191	CcSEcCtD
Nilutamide—Rash—Vincristine—hematologic cancer	3.61e-05	0.000191	CcSEcCtD
Nilutamide—Dermatitis—Vincristine—hematologic cancer	3.61e-05	0.00019	CcSEcCtD
Nilutamide—Oedema peripheral—Epirubicin—hematologic cancer	3.6e-05	0.00019	CcSEcCtD
Nilutamide—Pain—Triamcinolone—hematologic cancer	3.6e-05	0.00019	CcSEcCtD
Nilutamide—Haematuria—Doxorubicin—hematologic cancer	3.59e-05	0.00019	CcSEcCtD
Nilutamide—Urethral disorder—Epirubicin—hematologic cancer	3.59e-05	0.000189	CcSEcCtD
Nilutamide—Headache—Vincristine—hematologic cancer	3.59e-05	0.000189	CcSEcCtD
Nilutamide—Loss of consciousness—Prednisone—hematologic cancer	3.58e-05	0.000189	CcSEcCtD
Nilutamide—Nausea—Carmustine—hematologic cancer	3.56e-05	0.000188	CcSEcCtD
Nilutamide—Vomiting—Mitoxantrone—hematologic cancer	3.54e-05	0.000187	CcSEcCtD
Nilutamide—Vomiting—Irinotecan—hematologic cancer	3.54e-05	0.000187	CcSEcCtD
Nilutamide—Nausea—Alitretinoin—hematologic cancer	3.53e-05	0.000186	CcSEcCtD
Nilutamide—Visual impairment—Epirubicin—hematologic cancer	3.53e-05	0.000186	CcSEcCtD
Nilutamide—Hypertension—Prednisone—hematologic cancer	3.52e-05	0.000186	CcSEcCtD
Nilutamide—Rash—Irinotecan—hematologic cancer	3.51e-05	0.000186	CcSEcCtD
Nilutamide—Rash—Mitoxantrone—hematologic cancer	3.51e-05	0.000186	CcSEcCtD
Nilutamide—Dermatitis—Mitoxantrone—hematologic cancer	3.51e-05	0.000185	CcSEcCtD
Nilutamide—Dermatitis—Irinotecan—hematologic cancer	3.51e-05	0.000185	CcSEcCtD
Nilutamide—Headache—Irinotecan—hematologic cancer	3.49e-05	0.000184	CcSEcCtD
Nilutamide—Headache—Mitoxantrone—hematologic cancer	3.49e-05	0.000184	CcSEcCtD
Nilutamide—Nausea—Ifosfamide—hematologic cancer	3.49e-05	0.000184	CcSEcCtD
Nilutamide—Feeling abnormal—Triamcinolone—hematologic cancer	3.47e-05	0.000183	CcSEcCtD
Nilutamide—Diarrhoea—Cisplatin—hematologic cancer	3.46e-05	0.000183	CcSEcCtD
Nilutamide—Alopecia—Methotrexate—hematologic cancer	3.45e-05	0.000182	CcSEcCtD
Nilutamide—Vomiting—Gemcitabine—hematologic cancer	3.45e-05	0.000182	CcSEcCtD
Nilutamide—Insomnia—Betamethasone—hematologic cancer	3.45e-05	0.000182	CcSEcCtD
Nilutamide—Insomnia—Dexamethasone—hematologic cancer	3.45e-05	0.000182	CcSEcCtD
Nilutamide—Paraesthesia—Dexamethasone—hematologic cancer	3.43e-05	0.000181	CcSEcCtD
Nilutamide—Paraesthesia—Betamethasone—hematologic cancer	3.43e-05	0.000181	CcSEcCtD
Nilutamide—Discomfort—Prednisone—hematologic cancer	3.42e-05	0.000181	CcSEcCtD
Nilutamide—Rash—Gemcitabine—hematologic cancer	3.42e-05	0.000181	CcSEcCtD
Nilutamide—Dermatitis—Gemcitabine—hematologic cancer	3.42e-05	0.000181	CcSEcCtD
Nilutamide—Headache—Gemcitabine—hematologic cancer	3.4e-05	0.00018	CcSEcCtD
Nilutamide—Nausea—Vincristine—hematologic cancer	3.4e-05	0.000179	CcSEcCtD
Nilutamide—Rhinitis—Doxorubicin—hematologic cancer	3.39e-05	0.000179	CcSEcCtD
Nilutamide—Hypoaesthesia—Doxorubicin—hematologic cancer	3.37e-05	0.000178	CcSEcCtD
Nilutamide—Dyspepsia—Dexamethasone—hematologic cancer	3.36e-05	0.000177	CcSEcCtD
Nilutamide—Dyspepsia—Betamethasone—hematologic cancer	3.36e-05	0.000177	CcSEcCtD
Nilutamide—Urinary tract disorder—Doxorubicin—hematologic cancer	3.34e-05	0.000176	CcSEcCtD
Nilutamide—Oedema peripheral—Doxorubicin—hematologic cancer	3.33e-05	0.000176	CcSEcCtD
Nilutamide—Asthenia—Etoposide—hematologic cancer	3.33e-05	0.000176	CcSEcCtD
Nilutamide—Body temperature increased—Triamcinolone—hematologic cancer	3.32e-05	0.000176	CcSEcCtD
Nilutamide—Oedema—Prednisone—hematologic cancer	3.32e-05	0.000175	CcSEcCtD
Nilutamide—Urethral disorder—Doxorubicin—hematologic cancer	3.32e-05	0.000175	CcSEcCtD
Nilutamide—Decreased appetite—Betamethasone—hematologic cancer	3.32e-05	0.000175	CcSEcCtD
Nilutamide—Decreased appetite—Dexamethasone—hematologic cancer	3.32e-05	0.000175	CcSEcCtD
Nilutamide—Nausea—Irinotecan—hematologic cancer	3.31e-05	0.000175	CcSEcCtD
Nilutamide—Nausea—Mitoxantrone—hematologic cancer	3.31e-05	0.000175	CcSEcCtD
Nilutamide—Gastrointestinal disorder—Betamethasone—hematologic cancer	3.29e-05	0.000174	CcSEcCtD
Nilutamide—Gastrointestinal disorder—Dexamethasone—hematologic cancer	3.29e-05	0.000174	CcSEcCtD
Nilutamide—Back pain—Methotrexate—hematologic cancer	3.29e-05	0.000174	CcSEcCtD
Nilutamide—Pruritus—Etoposide—hematologic cancer	3.28e-05	0.000173	CcSEcCtD
Nilutamide—Shock—Prednisone—hematologic cancer	3.27e-05	0.000173	CcSEcCtD
Nilutamide—Pain—Dexamethasone—hematologic cancer	3.26e-05	0.000172	CcSEcCtD
Nilutamide—Pain—Betamethasone—hematologic cancer	3.26e-05	0.000172	CcSEcCtD
Nilutamide—Visual impairment—Doxorubicin—hematologic cancer	3.26e-05	0.000172	CcSEcCtD
Nilutamide—Alopecia—Epirubicin—hematologic cancer	3.23e-05	0.000171	CcSEcCtD
Nilutamide—Nausea—Gemcitabine—hematologic cancer	3.22e-05	0.00017	CcSEcCtD
Nilutamide—Vomiting—Cisplatin—hematologic cancer	3.22e-05	0.00017	CcSEcCtD
Nilutamide—Hyperhidrosis—Prednisone—hematologic cancer	3.21e-05	0.00017	CcSEcCtD
Nilutamide—Rash—Cisplatin—hematologic cancer	3.19e-05	0.000168	CcSEcCtD
Nilutamide—Dermatitis—Cisplatin—hematologic cancer	3.19e-05	0.000168	CcSEcCtD
Nilutamide—Diarrhoea—Etoposide—hematologic cancer	3.17e-05	0.000167	CcSEcCtD
Nilutamide—Anorexia—Prednisone—hematologic cancer	3.17e-05	0.000167	CcSEcCtD
Nilutamide—Ill-defined disorder—Methotrexate—hematologic cancer	3.16e-05	0.000167	CcSEcCtD
Nilutamide—Anaemia—Methotrexate—hematologic cancer	3.14e-05	0.000166	CcSEcCtD
Nilutamide—Feeling abnormal—Dexamethasone—hematologic cancer	3.14e-05	0.000166	CcSEcCtD
Nilutamide—Feeling abnormal—Betamethasone—hematologic cancer	3.14e-05	0.000166	CcSEcCtD
Nilutamide—Tension—Epirubicin—hematologic cancer	3.12e-05	0.000165	CcSEcCtD
Nilutamide—Gastrointestinal pain—Betamethasone—hematologic cancer	3.12e-05	0.000165	CcSEcCtD
Nilutamide—Gastrointestinal pain—Dexamethasone—hematologic cancer	3.12e-05	0.000165	CcSEcCtD
Nilutamide—Nervousness—Epirubicin—hematologic cancer	3.09e-05	0.000163	CcSEcCtD
Nilutamide—Back pain—Epirubicin—hematologic cancer	3.08e-05	0.000163	CcSEcCtD
Nilutamide—Malaise—Methotrexate—hematologic cancer	3.07e-05	0.000162	CcSEcCtD
Nilutamide—Dizziness—Etoposide—hematologic cancer	3.07e-05	0.000162	CcSEcCtD
Nilutamide—Leukopenia—Methotrexate—hematologic cancer	3.05e-05	0.000161	CcSEcCtD
Nilutamide—Dizziness—Prednisolone—hematologic cancer	3.02e-05	0.00016	CcSEcCtD
Nilutamide—Asthenia—Triamcinolone—hematologic cancer	3.02e-05	0.000159	CcSEcCtD
Nilutamide—Body temperature increased—Dexamethasone—hematologic cancer	3.02e-05	0.000159	CcSEcCtD
Nilutamide—Abdominal pain—Betamethasone—hematologic cancer	3.02e-05	0.000159	CcSEcCtD
Nilutamide—Abdominal pain—Dexamethasone—hematologic cancer	3.02e-05	0.000159	CcSEcCtD
Nilutamide—Body temperature increased—Betamethasone—hematologic cancer	3.02e-05	0.000159	CcSEcCtD
Nilutamide—Nausea—Cisplatin—hematologic cancer	3.01e-05	0.000159	CcSEcCtD
Nilutamide—Insomnia—Prednisone—hematologic cancer	3.01e-05	0.000159	CcSEcCtD
Nilutamide—Alopecia—Doxorubicin—hematologic cancer	2.99e-05	0.000158	CcSEcCtD
Nilutamide—Paraesthesia—Prednisone—hematologic cancer	2.98e-05	0.000158	CcSEcCtD
Nilutamide—Pruritus—Triamcinolone—hematologic cancer	2.98e-05	0.000157	CcSEcCtD
Nilutamide—Cough—Methotrexate—hematologic cancer	2.97e-05	0.000157	CcSEcCtD
Nilutamide—Ill-defined disorder—Epirubicin—hematologic cancer	2.95e-05	0.000156	CcSEcCtD
Nilutamide—Vomiting—Etoposide—hematologic cancer	2.95e-05	0.000156	CcSEcCtD
Nilutamide—Anaemia—Epirubicin—hematologic cancer	2.94e-05	0.000155	CcSEcCtD
Nilutamide—Dyspepsia—Prednisone—hematologic cancer	2.92e-05	0.000154	CcSEcCtD
Nilutamide—Rash—Etoposide—hematologic cancer	2.92e-05	0.000154	CcSEcCtD
Nilutamide—Dermatitis—Etoposide—hematologic cancer	2.92e-05	0.000154	CcSEcCtD
Nilutamide—Headache—Etoposide—hematologic cancer	2.9e-05	0.000153	CcSEcCtD
Nilutamide—Chest pain—Methotrexate—hematologic cancer	2.9e-05	0.000153	CcSEcCtD
Nilutamide—Tension—Doxorubicin—hematologic cancer	2.89e-05	0.000153	CcSEcCtD
Nilutamide—Decreased appetite—Prednisone—hematologic cancer	2.89e-05	0.000153	CcSEcCtD
Nilutamide—Rash—Prednisolone—hematologic cancer	2.88e-05	0.000152	CcSEcCtD
Nilutamide—Dermatitis—Prednisolone—hematologic cancer	2.88e-05	0.000152	CcSEcCtD
Nilutamide—Malaise—Epirubicin—hematologic cancer	2.87e-05	0.000152	CcSEcCtD
Nilutamide—Headache—Prednisolone—hematologic cancer	2.86e-05	0.000151	CcSEcCtD
Nilutamide—Discomfort—Methotrexate—hematologic cancer	2.86e-05	0.000151	CcSEcCtD
Nilutamide—Nervousness—Doxorubicin—hematologic cancer	2.86e-05	0.000151	CcSEcCtD
Nilutamide—Syncope—Epirubicin—hematologic cancer	2.86e-05	0.000151	CcSEcCtD
Nilutamide—Leukopenia—Epirubicin—hematologic cancer	2.85e-05	0.00015	CcSEcCtD
Nilutamide—Back pain—Doxorubicin—hematologic cancer	2.85e-05	0.00015	CcSEcCtD
Nilutamide—Constipation—Prednisone—hematologic cancer	2.84e-05	0.00015	CcSEcCtD
Nilutamide—Loss of consciousness—Epirubicin—hematologic cancer	2.8e-05	0.000148	CcSEcCtD
Nilutamide—Dizziness—Triamcinolone—hematologic cancer	2.78e-05	0.000147	CcSEcCtD
Nilutamide—Cough—Epirubicin—hematologic cancer	2.78e-05	0.000147	CcSEcCtD
Nilutamide—Nausea—Etoposide—hematologic cancer	2.75e-05	0.000145	CcSEcCtD
Nilutamide—Hypertension—Epirubicin—hematologic cancer	2.75e-05	0.000145	CcSEcCtD
Nilutamide—Feeling abnormal—Prednisone—hematologic cancer	2.74e-05	0.000145	CcSEcCtD
Nilutamide—Asthenia—Dexamethasone—hematologic cancer	2.74e-05	0.000145	CcSEcCtD
Nilutamide—Asthenia—Betamethasone—hematologic cancer	2.74e-05	0.000145	CcSEcCtD
Nilutamide—Ill-defined disorder—Doxorubicin—hematologic cancer	2.73e-05	0.000144	CcSEcCtD
Nilutamide—Anaemia—Doxorubicin—hematologic cancer	2.72e-05	0.000144	CcSEcCtD
Nilutamide—Gastrointestinal pain—Prednisone—hematologic cancer	2.72e-05	0.000143	CcSEcCtD
Nilutamide—Nausea—Prednisolone—hematologic cancer	2.72e-05	0.000143	CcSEcCtD
Nilutamide—Chest pain—Epirubicin—hematologic cancer	2.71e-05	0.000143	CcSEcCtD
Nilutamide—Pruritus—Betamethasone—hematologic cancer	2.7e-05	0.000143	CcSEcCtD
Nilutamide—Pruritus—Dexamethasone—hematologic cancer	2.7e-05	0.000143	CcSEcCtD
Nilutamide—Hyperhidrosis—Methotrexate—hematologic cancer	2.68e-05	0.000142	CcSEcCtD
Nilutamide—Discomfort—Epirubicin—hematologic cancer	2.68e-05	0.000141	CcSEcCtD
Nilutamide—Vomiting—Triamcinolone—hematologic cancer	2.67e-05	0.000141	CcSEcCtD
Nilutamide—Malaise—Doxorubicin—hematologic cancer	2.66e-05	0.00014	CcSEcCtD
Nilutamide—Rash—Triamcinolone—hematologic cancer	2.65e-05	0.00014	CcSEcCtD
Nilutamide—Dry mouth—Epirubicin—hematologic cancer	2.65e-05	0.00014	CcSEcCtD
Nilutamide—Dermatitis—Triamcinolone—hematologic cancer	2.65e-05	0.00014	CcSEcCtD
Nilutamide—Anorexia—Methotrexate—hematologic cancer	2.65e-05	0.00014	CcSEcCtD
Nilutamide—Syncope—Doxorubicin—hematologic cancer	2.64e-05	0.00014	CcSEcCtD
Nilutamide—Leukopenia—Doxorubicin—hematologic cancer	2.64e-05	0.000139	CcSEcCtD
Nilutamide—Headache—Triamcinolone—hematologic cancer	2.63e-05	0.000139	CcSEcCtD
Nilutamide—Body temperature increased—Prednisone—hematologic cancer	2.63e-05	0.000139	CcSEcCtD
Nilutamide—Abdominal pain—Prednisone—hematologic cancer	2.63e-05	0.000139	CcSEcCtD
Nilutamide—Diarrhoea—Dexamethasone—hematologic cancer	2.61e-05	0.000138	CcSEcCtD
Nilutamide—Diarrhoea—Betamethasone—hematologic cancer	2.61e-05	0.000138	CcSEcCtD
Nilutamide—Oedema—Epirubicin—hematologic cancer	2.6e-05	0.000137	CcSEcCtD
Nilutamide—Loss of consciousness—Doxorubicin—hematologic cancer	2.59e-05	0.000137	CcSEcCtD
Nilutamide—Cough—Doxorubicin—hematologic cancer	2.57e-05	0.000136	CcSEcCtD
Nilutamide—Shock—Epirubicin—hematologic cancer	2.56e-05	0.000135	CcSEcCtD
Nilutamide—Hypertension—Doxorubicin—hematologic cancer	2.54e-05	0.000134	CcSEcCtD
Nilutamide—Dizziness—Dexamethasone—hematologic cancer	2.52e-05	0.000133	CcSEcCtD
Nilutamide—Dizziness—Betamethasone—hematologic cancer	2.52e-05	0.000133	CcSEcCtD
Nilutamide—Hyperhidrosis—Epirubicin—hematologic cancer	2.51e-05	0.000133	CcSEcCtD
Nilutamide—Insomnia—Methotrexate—hematologic cancer	2.51e-05	0.000133	CcSEcCtD
Nilutamide—Chest pain—Doxorubicin—hematologic cancer	2.51e-05	0.000132	CcSEcCtD
Nilutamide—Nausea—Triamcinolone—hematologic cancer	2.5e-05	0.000132	CcSEcCtD
Nilutamide—Paraesthesia—Methotrexate—hematologic cancer	2.49e-05	0.000132	CcSEcCtD
Nilutamide—Discomfort—Doxorubicin—hematologic cancer	2.48e-05	0.000131	CcSEcCtD
Nilutamide—Anorexia—Epirubicin—hematologic cancer	2.48e-05	0.000131	CcSEcCtD
Nilutamide—Dyspnoea—Methotrexate—hematologic cancer	2.48e-05	0.000131	CcSEcCtD
Nilutamide—Dry mouth—Doxorubicin—hematologic cancer	2.45e-05	0.00013	CcSEcCtD
Nilutamide—Dyspepsia—Methotrexate—hematologic cancer	2.44e-05	0.000129	CcSEcCtD
Nilutamide—Vomiting—Dexamethasone—hematologic cancer	2.43e-05	0.000128	CcSEcCtD
Nilutamide—Vomiting—Betamethasone—hematologic cancer	2.43e-05	0.000128	CcSEcCtD
Nilutamide—Decreased appetite—Methotrexate—hematologic cancer	2.41e-05	0.000127	CcSEcCtD
Nilutamide—Rash—Dexamethasone—hematologic cancer	2.41e-05	0.000127	CcSEcCtD
Nilutamide—Rash—Betamethasone—hematologic cancer	2.41e-05	0.000127	CcSEcCtD
Nilutamide—Oedema—Doxorubicin—hematologic cancer	2.4e-05	0.000127	CcSEcCtD
Nilutamide—Dermatitis—Betamethasone—hematologic cancer	2.4e-05	0.000127	CcSEcCtD
Nilutamide—Dermatitis—Dexamethasone—hematologic cancer	2.4e-05	0.000127	CcSEcCtD
Nilutamide—Gastrointestinal disorder—Methotrexate—hematologic cancer	2.4e-05	0.000127	CcSEcCtD
Nilutamide—Headache—Betamethasone—hematologic cancer	2.39e-05	0.000126	CcSEcCtD
Nilutamide—Headache—Dexamethasone—hematologic cancer	2.39e-05	0.000126	CcSEcCtD
Nilutamide—Asthenia—Prednisone—hematologic cancer	2.38e-05	0.000126	CcSEcCtD
Nilutamide—Pain—Methotrexate—hematologic cancer	2.37e-05	0.000125	CcSEcCtD
Nilutamide—Shock—Doxorubicin—hematologic cancer	2.37e-05	0.000125	CcSEcCtD
Nilutamide—Pruritus—Prednisone—hematologic cancer	2.35e-05	0.000124	CcSEcCtD
Nilutamide—Insomnia—Epirubicin—hematologic cancer	2.35e-05	0.000124	CcSEcCtD
Nilutamide—Paraesthesia—Epirubicin—hematologic cancer	2.33e-05	0.000123	CcSEcCtD
Nilutamide—Hyperhidrosis—Doxorubicin—hematologic cancer	2.32e-05	0.000123	CcSEcCtD
Nilutamide—Dyspnoea—Epirubicin—hematologic cancer	2.32e-05	0.000122	CcSEcCtD
Nilutamide—Anorexia—Doxorubicin—hematologic cancer	2.29e-05	0.000121	CcSEcCtD
Nilutamide—Feeling abnormal—Methotrexate—hematologic cancer	2.29e-05	0.000121	CcSEcCtD
Nilutamide—Dyspepsia—Epirubicin—hematologic cancer	2.29e-05	0.000121	CcSEcCtD
Nilutamide—Diarrhoea—Prednisone—hematologic cancer	2.27e-05	0.00012	CcSEcCtD
Nilutamide—Gastrointestinal pain—Methotrexate—hematologic cancer	2.27e-05	0.00012	CcSEcCtD
Nilutamide—Nausea—Betamethasone—hematologic cancer	2.27e-05	0.00012	CcSEcCtD
Nilutamide—Nausea—Dexamethasone—hematologic cancer	2.27e-05	0.00012	CcSEcCtD
Nilutamide—Decreased appetite—Epirubicin—hematologic cancer	2.26e-05	0.000119	CcSEcCtD
Nilutamide—Gastrointestinal disorder—Epirubicin—hematologic cancer	2.24e-05	0.000118	CcSEcCtD
Nilutamide—Pain—Epirubicin—hematologic cancer	2.22e-05	0.000117	CcSEcCtD
Nilutamide—Constipation—Epirubicin—hematologic cancer	2.22e-05	0.000117	CcSEcCtD
Nilutamide—Dizziness—Prednisone—hematologic cancer	2.2e-05	0.000116	CcSEcCtD
Nilutamide—Abdominal pain—Methotrexate—hematologic cancer	2.2e-05	0.000116	CcSEcCtD
Nilutamide—Body temperature increased—Methotrexate—hematologic cancer	2.2e-05	0.000116	CcSEcCtD
Nilutamide—Insomnia—Doxorubicin—hematologic cancer	2.17e-05	0.000115	CcSEcCtD
Nilutamide—Paraesthesia—Doxorubicin—hematologic cancer	2.16e-05	0.000114	CcSEcCtD
Nilutamide—Dyspnoea—Doxorubicin—hematologic cancer	2.14e-05	0.000113	CcSEcCtD
Nilutamide—Feeling abnormal—Epirubicin—hematologic cancer	2.14e-05	0.000113	CcSEcCtD
Nilutamide—Gastrointestinal pain—Epirubicin—hematologic cancer	2.13e-05	0.000112	CcSEcCtD
Nilutamide—Dyspepsia—Doxorubicin—hematologic cancer	2.12e-05	0.000112	CcSEcCtD
Nilutamide—Vomiting—Prednisone—hematologic cancer	2.11e-05	0.000112	CcSEcCtD
Nilutamide—Rash—Prednisone—hematologic cancer	2.1e-05	0.000111	CcSEcCtD
Nilutamide—Dermatitis—Prednisone—hematologic cancer	2.09e-05	0.000111	CcSEcCtD
Nilutamide—Decreased appetite—Doxorubicin—hematologic cancer	2.09e-05	0.00011	CcSEcCtD
Nilutamide—Headache—Prednisone—hematologic cancer	2.08e-05	0.00011	CcSEcCtD
Nilutamide—Gastrointestinal disorder—Doxorubicin—hematologic cancer	2.08e-05	0.00011	CcSEcCtD
Nilutamide—Constipation—Doxorubicin—hematologic cancer	2.06e-05	0.000109	CcSEcCtD
Nilutamide—Pain—Doxorubicin—hematologic cancer	2.06e-05	0.000109	CcSEcCtD
Nilutamide—Body temperature increased—Epirubicin—hematologic cancer	2.05e-05	0.000108	CcSEcCtD
Nilutamide—Abdominal pain—Epirubicin—hematologic cancer	2.05e-05	0.000108	CcSEcCtD
Nilutamide—Asthenia—Methotrexate—hematologic cancer	1.99e-05	0.000105	CcSEcCtD
Nilutamide—Feeling abnormal—Doxorubicin—hematologic cancer	1.98e-05	0.000105	CcSEcCtD
Nilutamide—Nausea—Prednisone—hematologic cancer	1.97e-05	0.000104	CcSEcCtD
Nilutamide—Gastrointestinal pain—Doxorubicin—hematologic cancer	1.97e-05	0.000104	CcSEcCtD
Nilutamide—Pruritus—Methotrexate—hematologic cancer	1.96e-05	0.000104	CcSEcCtD
Nilutamide—Body temperature increased—Doxorubicin—hematologic cancer	1.9e-05	0.0001	CcSEcCtD
Nilutamide—Abdominal pain—Doxorubicin—hematologic cancer	1.9e-05	0.0001	CcSEcCtD
Nilutamide—Diarrhoea—Methotrexate—hematologic cancer	1.9e-05	0.0001	CcSEcCtD
Nilutamide—Asthenia—Epirubicin—hematologic cancer	1.86e-05	9.85e-05	CcSEcCtD
Nilutamide—Pruritus—Epirubicin—hematologic cancer	1.84e-05	9.71e-05	CcSEcCtD
Nilutamide—Dizziness—Methotrexate—hematologic cancer	1.84e-05	9.7e-05	CcSEcCtD
Nilutamide—CYP2C8—Metabolism—SMPD3—hematologic cancer	1.83e-05	0.000549	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism of lipids and lipoproteins—SPHK1—hematologic cancer	1.82e-05	0.000547	CbGpPWpGaD
Nilutamide—AR—Integrated Pancreatic Cancer Pathway—TNF—hematologic cancer	1.79e-05	0.000538	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism—PHYH—hematologic cancer	1.78e-05	0.000535	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism—FTCD—hematologic cancer	1.78e-05	0.000535	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism—GMPS—hematologic cancer	1.78e-05	0.000535	CbGpPWpGaD
Nilutamide—AR—Integrated Pancreatic Cancer Pathway—KRAS—hematologic cancer	1.78e-05	0.000534	CbGpPWpGaD
Nilutamide—Diarrhoea—Epirubicin—hematologic cancer	1.78e-05	9.39e-05	CcSEcCtD
Nilutamide—AR—Generic Transcription Pathway—NOTCH1—hematologic cancer	1.78e-05	0.000533	CbGpPWpGaD
Nilutamide—Vomiting—Methotrexate—hematologic cancer	1.77e-05	9.32e-05	CcSEcCtD
Nilutamide—CYP2C19—Metabolism of lipids and lipoproteins—NCOR2—hematologic cancer	1.77e-05	0.00053	CbGpPWpGaD
Nilutamide—Rash—Methotrexate—hematologic cancer	1.75e-05	9.25e-05	CcSEcCtD
Nilutamide—Dermatitis—Methotrexate—hematologic cancer	1.75e-05	9.24e-05	CcSEcCtD
Nilutamide—AR—Gene Expression—EIF4EBP1—hematologic cancer	1.75e-05	0.000525	CbGpPWpGaD
Nilutamide—AR—Gene Expression—HSPB1—hematologic cancer	1.75e-05	0.000525	CbGpPWpGaD
Nilutamide—Headache—Methotrexate—hematologic cancer	1.74e-05	9.19e-05	CcSEcCtD
Nilutamide—Asthenia—Doxorubicin—hematologic cancer	1.73e-05	9.11e-05	CcSEcCtD
Nilutamide—Dizziness—Epirubicin—hematologic cancer	1.72e-05	9.07e-05	CcSEcCtD
Nilutamide—CYP2C8—Metabolism of lipids and lipoproteins—CRABP1—hematologic cancer	1.7e-05	0.000512	CbGpPWpGaD
Nilutamide—Pruritus—Doxorubicin—hematologic cancer	1.7e-05	8.98e-05	CcSEcCtD
Nilutamide—AR—SIDS Susceptibility Pathways—IL6—hematologic cancer	1.7e-05	0.000511	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism of lipids and lipoproteins—IDH1—hematologic cancer	1.68e-05	0.000505	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism of lipids and lipoproteins—ARNTL—hematologic cancer	1.68e-05	0.000503	CbGpPWpGaD
Nilutamide—AR—Gene Expression—SMC1A—hematologic cancer	1.67e-05	0.000503	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism of lipids and lipoproteins—ABCC3—hematologic cancer	1.66e-05	0.000499	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism of lipids and lipoproteins—ALOX5—hematologic cancer	1.66e-05	0.000499	CbGpPWpGaD
Nilutamide—Vomiting—Epirubicin—hematologic cancer	1.65e-05	8.72e-05	CcSEcCtD
Nilutamide—Nausea—Methotrexate—hematologic cancer	1.65e-05	8.71e-05	CcSEcCtD
Nilutamide—Diarrhoea—Doxorubicin—hematologic cancer	1.65e-05	8.69e-05	CcSEcCtD
Nilutamide—AR—Gene Expression—H3F3A—hematologic cancer	1.64e-05	0.000493	CbGpPWpGaD
Nilutamide—Rash—Epirubicin—hematologic cancer	1.64e-05	8.65e-05	CcSEcCtD
Nilutamide—Dermatitis—Epirubicin—hematologic cancer	1.64e-05	8.64e-05	CcSEcCtD
Nilutamide—AR—Integrated Pancreatic Cancer Pathway—PIK3CA—hematologic cancer	1.63e-05	0.00049	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism—SMPD3—hematologic cancer	1.63e-05	0.00049	CbGpPWpGaD
Nilutamide—Headache—Epirubicin—hematologic cancer	1.63e-05	8.6e-05	CcSEcCtD
Nilutamide—CYP2C19—Metabolism of lipids and lipoproteins—SPHK1—hematologic cancer	1.63e-05	0.000489	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism—GMPS—hematologic cancer	1.63e-05	0.000488	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism—FTCD—hematologic cancer	1.63e-05	0.000488	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism—PHYH—hematologic cancer	1.63e-05	0.000488	CbGpPWpGaD
Nilutamide—AR—Generic Transcription Pathway—CREBBP—hematologic cancer	1.61e-05	0.000484	CbGpPWpGaD
Nilutamide—AR—Integrated Breast Cancer Pathway—AKT1—hematologic cancer	1.61e-05	0.000484	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism of lipids and lipoproteins—NCOR2—hematologic cancer	1.61e-05	0.000483	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism—ASNS—hematologic cancer	1.6e-05	0.00048	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism—DCK—hematologic cancer	1.6e-05	0.00048	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism—B3GAT1—hematologic cancer	1.6e-05	0.00048	CbGpPWpGaD
Nilutamide—Dizziness—Doxorubicin—hematologic cancer	1.59e-05	8.4e-05	CcSEcCtD
Nilutamide—AR—Integrated Pancreatic Cancer Pathway—TP53—hematologic cancer	1.58e-05	0.000474	CbGpPWpGaD
Nilutamide—AR—Gene Expression—EZH2—hematologic cancer	1.57e-05	0.000473	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism of lipids and lipoproteins—NCOA3—hematologic cancer	1.56e-05	0.000469	CbGpPWpGaD
Nilutamide—Nausea—Epirubicin—hematologic cancer	1.54e-05	8.15e-05	CcSEcCtD
Nilutamide—AR—Gene Expression—PARP1—hematologic cancer	1.54e-05	0.000463	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism of lipids and lipoproteins—IDH1—hematologic cancer	1.53e-05	0.00046	CbGpPWpGaD
Nilutamide—Vomiting—Doxorubicin—hematologic cancer	1.53e-05	8.07e-05	CcSEcCtD
Nilutamide—CYP2C19—Metabolism of lipids and lipoproteins—CRABP1—hematologic cancer	1.52e-05	0.000457	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism of lipids and lipoproteins—ABCC3—hematologic cancer	1.52e-05	0.000455	CbGpPWpGaD
Nilutamide—Rash—Doxorubicin—hematologic cancer	1.52e-05	8.01e-05	CcSEcCtD
Nilutamide—Dermatitis—Doxorubicin—hematologic cancer	1.51e-05	8e-05	CcSEcCtD
Nilutamide—CYP2C8—Metabolism—HDC—hematologic cancer	1.51e-05	0.000455	CbGpPWpGaD
Nilutamide—Headache—Doxorubicin—hematologic cancer	1.51e-05	7.95e-05	CcSEcCtD
Nilutamide—CYP2C9—Metabolism—SMPD3—hematologic cancer	1.49e-05	0.000447	CbGpPWpGaD
Nilutamide—AR—Gene Expression—HDAC2—hematologic cancer	1.49e-05	0.000446	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism of lipids and lipoproteins—SPHK1—hematologic cancer	1.48e-05	0.000445	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism of lipids and lipoproteins—ALOX5—hematologic cancer	1.48e-05	0.000445	CbGpPWpGaD
Nilutamide—Nausea—Doxorubicin—hematologic cancer	1.43e-05	7.54e-05	CcSEcCtD
Nilutamide—CYP2C19—Metabolism—ASNS—hematologic cancer	1.43e-05	0.000428	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism—B3GAT1—hematologic cancer	1.43e-05	0.000428	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism—DCK—hematologic cancer	1.43e-05	0.000428	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism of lipids and lipoproteins—SDC1—hematologic cancer	1.41e-05	0.000424	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism of lipids and lipoproteins—NCOA3—hematologic cancer	1.39e-05	0.000418	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism of lipids and lipoproteins—CRABP1—hematologic cancer	1.39e-05	0.000416	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism—CDA—hematologic cancer	1.38e-05	0.000416	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism—HDC—hematologic cancer	1.35e-05	0.000406	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism of lipids and lipoproteins—ALOX5—hematologic cancer	1.35e-05	0.000406	CbGpPWpGaD
Nilutamide—AR—Integrated Pancreatic Cancer Pathway—AKT1—hematologic cancer	1.33e-05	0.000401	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism—PC—hematologic cancer	1.33e-05	0.0004	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism—DCK—hematologic cancer	1.3e-05	0.00039	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism—B3GAT1—hematologic cancer	1.3e-05	0.00039	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism—ASNS—hematologic cancer	1.3e-05	0.00039	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism—SLC35B2—hematologic cancer	1.29e-05	0.000387	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism—GBA—hematologic cancer	1.29e-05	0.000387	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism of lipids and lipoproteins—NCOA3—hematologic cancer	1.27e-05	0.000381	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism of lipids and lipoproteins—SDC1—hematologic cancer	1.26e-05	0.000378	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism—CDA—hematologic cancer	1.24e-05	0.000371	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism—HDC—hematologic cancer	1.23e-05	0.00037	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism—PC—hematologic cancer	1.19e-05	0.000357	CbGpPWpGaD
Nilutamide—AR—Gene Expression—CDKN2B—hematologic cancer	1.19e-05	0.000357	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism—MTAP—hematologic cancer	1.18e-05	0.000354	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism—GBA—hematologic cancer	1.15e-05	0.000345	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism—SLC35B2—hematologic cancer	1.15e-05	0.000345	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism of lipids and lipoproteins—SDC1—hematologic cancer	1.15e-05	0.000345	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism—CDA—hematologic cancer	1.13e-05	0.000338	CbGpPWpGaD
Nilutamide—AR—Gene Expression—NCOR1—hematologic cancer	1.13e-05	0.000338	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism—PC—hematologic cancer	1.09e-05	0.000326	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism—MTAP—hematologic cancer	1.05e-05	0.000316	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism—FHL2—hematologic cancer	1.05e-05	0.000315	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism—GBA—hematologic cancer	1.05e-05	0.000315	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism—SLC35B2—hematologic cancer	1.05e-05	0.000315	CbGpPWpGaD
Nilutamide—AR—Gene Expression—NR3C1—hematologic cancer	1.04e-05	0.000313	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism—AGRN—hematologic cancer	1.03e-05	0.000309	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism—IDH2—hematologic cancer	9.76e-06	0.000293	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism—HMMR—hematologic cancer	9.76e-06	0.000293	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism—MTAP—hematologic cancer	9.58e-06	0.000288	CbGpPWpGaD
Nilutamide—AR—Generic Transcription Pathway—MYC—hematologic cancer	9.56e-06	0.000287	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism—FHL2—hematologic cancer	9.37e-06	0.000281	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism of lipids and lipoproteins—NCOR1—hematologic cancer	9.2e-06	0.000276	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism—AGRN—hematologic cancer	9.19e-06	0.000276	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism—ARNTL—hematologic cancer	9.17e-06	0.000275	CbGpPWpGaD
Nilutamide—AR—Gene Expression—MAPK14—hematologic cancer	9.02e-06	0.000271	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism—CA9—hematologic cancer	8.92e-06	0.000268	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism—ACP5—hematologic cancer	8.92e-06	0.000268	CbGpPWpGaD
Nilutamide—AR—Gene Expression—ESR1—hematologic cancer	8.85e-06	0.000266	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism—NCOR2—hematologic cancer	8.81e-06	0.000264	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism—IDH2—hematologic cancer	8.71e-06	0.000261	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism—HMMR—hematologic cancer	8.71e-06	0.000261	CbGpPWpGaD
Nilutamide—AR—Gene Expression—NOTCH1—hematologic cancer	8.55e-06	0.000257	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism—FHL2—hematologic cancer	8.54e-06	0.000256	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism—IDH1—hematologic cancer	8.39e-06	0.000252	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism—AGRN—hematologic cancer	8.38e-06	0.000252	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism—ABCC3—hematologic cancer	8.3e-06	0.000249	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism—TXN—hematologic cancer	8.3e-06	0.000249	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism—GSTO1—hematologic cancer	8.3e-06	0.000249	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism of lipids and lipoproteins—NCOR1—hematologic cancer	8.21e-06	0.000247	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism—ARNTL—hematologic cancer	8.19e-06	0.000246	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism—SPHK1—hematologic cancer	8.12e-06	0.000244	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism—CA9—hematologic cancer	7.97e-06	0.000239	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism—ACP5—hematologic cancer	7.97e-06	0.000239	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism—IDH2—hematologic cancer	7.94e-06	0.000238	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism—HMMR—hematologic cancer	7.94e-06	0.000238	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism—NCOR2—hematologic cancer	7.86e-06	0.000236	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism—UGT1A1—hematologic cancer	7.8e-06	0.000234	CbGpPWpGaD
Nilutamide—AR—Gene Expression—CREBBP—hematologic cancer	7.76e-06	0.000233	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism—SLC22A1—hematologic cancer	7.59e-06	0.000228	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism—CRABP1—hematologic cancer	7.59e-06	0.000228	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism—IDH1—hematologic cancer	7.49e-06	0.000225	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism of lipids and lipoproteins—NCOR1—hematologic cancer	7.49e-06	0.000225	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism—ARNTL—hematologic cancer	7.47e-06	0.000224	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism—TXN—hematologic cancer	7.41e-06	0.000222	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism—ABCC3—hematologic cancer	7.41e-06	0.000222	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism—GSTO1—hematologic cancer	7.41e-06	0.000222	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism—ALOX5—hematologic cancer	7.4e-06	0.000222	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism—CA9—hematologic cancer	7.26e-06	0.000218	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism—ACP5—hematologic cancer	7.26e-06	0.000218	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism—SPHK1—hematologic cancer	7.25e-06	0.000218	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism—NCOR2—hematologic cancer	7.17e-06	0.000215	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism—NUP98—hematologic cancer	7.16e-06	0.000215	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism—UGT1A1—hematologic cancer	6.96e-06	0.000209	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism—NCOA3—hematologic cancer	6.95e-06	0.000209	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism—ADCY7—hematologic cancer	6.95e-06	0.000209	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism—NUP214—hematologic cancer	6.9e-06	0.000207	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CG—hematologic cancer	6.83e-06	0.000205	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism—IDH1—hematologic cancer	6.83e-06	0.000205	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism—SLC22A1—hematologic cancer	6.77e-06	0.000203	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism—CRABP1—hematologic cancer	6.77e-06	0.000203	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism—MTR—hematologic cancer	6.76e-06	0.000203	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism—ABCG2—hematologic cancer	6.76e-06	0.000203	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism—GSTO1—hematologic cancer	6.75e-06	0.000203	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism—TXN—hematologic cancer	6.75e-06	0.000203	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism—ABCC3—hematologic cancer	6.75e-06	0.000203	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism—ENO2—hematologic cancer	6.63e-06	0.000199	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism—SPHK1—hematologic cancer	6.61e-06	0.000198	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism—ALOX5—hematologic cancer	6.6e-06	0.000198	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism—GSTT1—hematologic cancer	6.43e-06	0.000193	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism—NUP98—hematologic cancer	6.39e-06	0.000192	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism—UGT1A1—hematologic cancer	6.35e-06	0.000191	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism of lipids and lipoproteins—CREBBP—hematologic cancer	6.33e-06	0.00019	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism—SDC1—hematologic cancer	6.29e-06	0.000189	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism—ADCY7—hematologic cancer	6.21e-06	0.000186	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism—NCOA3—hematologic cancer	6.21e-06	0.000186	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism—CRABP1—hematologic cancer	6.18e-06	0.000185	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism—SLC22A1—hematologic cancer	6.18e-06	0.000185	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism—NUP214—hematologic cancer	6.16e-06	0.000185	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CG—hematologic cancer	6.1e-06	0.000183	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism—MTR—hematologic cancer	6.04e-06	0.000181	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism—ABCG2—hematologic cancer	6.04e-06	0.000181	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism—ALOX5—hematologic cancer	6.02e-06	0.000181	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CD—hematologic cancer	6.01e-06	0.00018	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism of lipids and lipoproteins—ALB—hematologic cancer	5.93e-06	0.000178	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism—ENO2—hematologic cancer	5.92e-06	0.000178	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism—NUP98—hematologic cancer	5.83e-06	0.000175	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism—GSTT1—hematologic cancer	5.74e-06	0.000172	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism of lipids and lipoproteins—PIK3R1—hematologic cancer	5.67e-06	0.00017	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism—ADCY7—hematologic cancer	5.66e-06	0.00017	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism—NCOA3—hematologic cancer	5.66e-06	0.00017	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism of lipids and lipoproteins—CREBBP—hematologic cancer	5.65e-06	0.00017	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism—NUP214—hematologic cancer	5.62e-06	0.000169	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism—SDC1—hematologic cancer	5.61e-06	0.000169	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—hematologic cancer	5.56e-06	0.000167	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism—MTR—hematologic cancer	5.5e-06	0.000165	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism—ABCG2—hematologic cancer	5.5e-06	0.000165	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism—ENO2—hematologic cancer	5.4e-06	0.000162	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CD—hematologic cancer	5.36e-06	0.000161	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism—CD44—hematologic cancer	5.35e-06	0.000161	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism—NQO1—hematologic cancer	5.35e-06	0.000161	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism of lipids and lipoproteins—ALB—hematologic cancer	5.29e-06	0.000159	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism—GSTT1—hematologic cancer	5.24e-06	0.000157	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CB—hematologic cancer	5.24e-06	0.000157	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism of lipids and lipoproteins—CREBBP—hematologic cancer	5.16e-06	0.000155	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism—SDC1—hematologic cancer	5.12e-06	0.000154	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism of lipids and lipoproteins—PIK3R1—hematologic cancer	5.06e-06	0.000152	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism—CYCS—hematologic cancer	5.06e-06	0.000152	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism—HSP90AA1—hematologic cancer	5.03e-06	0.000151	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CD—hematologic cancer	4.89e-06	0.000147	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism of lipids and lipoproteins—ALB—hematologic cancer	4.83e-06	0.000145	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism—CD44—hematologic cancer	4.77e-06	0.000143	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism—NQO1—hematologic cancer	4.77e-06	0.000143	CbGpPWpGaD
Nilutamide—AR—Gene Expression—MAPK3—hematologic cancer	4.73e-06	0.000142	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CB—hematologic cancer	4.67e-06	0.00014	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism of lipids and lipoproteins—PIK3R1—hematologic cancer	4.62e-06	0.000139	CbGpPWpGaD
Nilutamide—AR—Gene Expression—MYC—hematologic cancer	4.6e-06	0.000138	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism of lipids and lipoproteins—PTEN—hematologic cancer	4.52e-06	0.000136	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism—CYCS—hematologic cancer	4.52e-06	0.000136	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism—HSP90AA1—hematologic cancer	4.49e-06	0.000135	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism—GSTP1—hematologic cancer	4.46e-06	0.000134	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism—CD44—hematologic cancer	4.35e-06	0.000131	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism—NQO1—hematologic cancer	4.35e-06	0.000131	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism of lipids and lipoproteins—EP300—hematologic cancer	4.31e-06	0.00013	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—hematologic cancer	4.26e-06	0.000128	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism—ABCB1—hematologic cancer	4.22e-06	0.000127	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism—CYCS—hematologic cancer	4.12e-06	0.000124	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism—NCOR1—hematologic cancer	4.1e-06	0.000123	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism—GSTM1—hematologic cancer	4.1e-06	0.000123	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism—HSP90AA1—hematologic cancer	4.09e-06	0.000123	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—hematologic cancer	4.04e-06	0.000121	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism—GSTP1—hematologic cancer	3.98e-06	0.000119	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism of lipids and lipoproteins—EP300—hematologic cancer	3.85e-06	0.000116	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism—ABCB1—hematologic cancer	3.77e-06	0.000113	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—hematologic cancer	3.68e-06	0.000111	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism—GSTM1—hematologic cancer	3.66e-06	0.00011	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism—NCOR1—hematologic cancer	3.66e-06	0.00011	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism—GSTP1—hematologic cancer	3.63e-06	0.000109	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism—MTHFR—hematologic cancer	3.62e-06	0.000109	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism of lipids and lipoproteins—EP300—hematologic cancer	3.51e-06	0.000105	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism—ABCB1—hematologic cancer	3.44e-06	0.000103	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism—NCOR1—hematologic cancer	3.34e-06	0.0001	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism—GSTM1—hematologic cancer	3.34e-06	0.0001	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism—MTHFR—hematologic cancer	3.23e-06	9.71e-05	CbGpPWpGaD
Nilutamide—AR—Gene Expression—AKT1—hematologic cancer	3.19e-06	9.58e-05	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—hematologic cancer	3.19e-06	9.58e-05	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism—PIK3CG—hematologic cancer	3.04e-06	9.14e-05	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism—MTHFR—hematologic cancer	2.95e-06	8.85e-05	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—hematologic cancer	2.85e-06	8.55e-05	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism—CREBBP—hematologic cancer	2.82e-06	8.47e-05	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism—PIK3CG—hematologic cancer	2.72e-06	8.15e-05	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism—PIK3CD—hematologic cancer	2.67e-06	8.03e-05	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism—ALB—hematologic cancer	2.64e-06	7.93e-05	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—hematologic cancer	2.6e-06	7.8e-05	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism—PIK3R1—hematologic cancer	2.53e-06	7.58e-05	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism—CREBBP—hematologic cancer	2.52e-06	7.56e-05	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism—PIK3CG—hematologic cancer	2.48e-06	7.43e-05	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism—PIK3CD—hematologic cancer	2.39e-06	7.17e-05	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism—ALB—hematologic cancer	2.36e-06	7.08e-05	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism—PIK3CB—hematologic cancer	2.33e-06	7e-05	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism—CREBBP—hematologic cancer	2.3e-06	6.89e-05	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism—PIK3R1—hematologic cancer	2.25e-06	6.77e-05	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism—PIK3CD—hematologic cancer	2.18e-06	6.54e-05	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism—ALB—hematologic cancer	2.15e-06	6.45e-05	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism—PIK3CB—hematologic cancer	2.08e-06	6.25e-05	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism—PIK3R1—hematologic cancer	2.06e-06	6.17e-05	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism—PTEN—hematologic cancer	2.01e-06	6.05e-05	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism—EP300—hematologic cancer	1.92e-06	5.77e-05	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism—PIK3CB—hematologic cancer	1.9e-06	5.7e-05	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism—PTEN—hematologic cancer	1.8e-06	5.4e-05	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism—EP300—hematologic cancer	1.71e-06	5.15e-05	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism—PTEN—hematologic cancer	1.64e-06	4.92e-05	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism—EP300—hematologic cancer	1.56e-06	4.69e-05	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism—PIK3CA—hematologic cancer	1.42e-06	4.27e-05	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism—PIK3CA—hematologic cancer	1.27e-06	3.81e-05	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism—AKT1—hematologic cancer	1.16e-06	3.49e-05	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism—PIK3CA—hematologic cancer	1.16e-06	3.47e-05	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism—AKT1—hematologic cancer	1.04e-06	3.11e-05	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism—AKT1—hematologic cancer	9.45e-07	2.84e-05	CbGpPWpGaD
